Does Missouri Medicaid Cover Wegovy or Zepbound?
Missouri (MO) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Missouri Medicaid cover weight-loss GLP-1s, has Missouri expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Missouri Medicaid GLP-1 coverage: what the state's own documents say
MO HealthNet covers Zepbound and Foundayo for obesity with prior authorization (BMI 30 or higher, or 27 or higher with a weight-related condition, plus other pathways); Wegovy and Saxenda are not covered for weight loss.
Checked September 20, 2026 against: dss.mo.gov, dss.mo.gov, dss.mo.gov, dss.mo.gov.
Missouri state employee health plan: what the plan's own documents say
Not verified. None of MCHCP's public plan documents says whether Wegovy, Zepbound, Saxenda or Foundayo are covered for weight loss (the 2026 enrollment guide has no GLP-1 language and the 2026 summary of benefits excludes only 'Weight-loss programs'); the plan's formulary sits behind the member login.
Checked September 20, 2026 against: mchcp.org, sos.mo.gov.
Notable insurers active in Missouri (not independently verified): Anthem Blue Cross Blue Shield, Cigna, UnitedHealthcare.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Missouri is one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Missouri-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Missouri residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Missouri carrier coverage details
National carriers active in Missouri (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does Missouri Medicaid cover Wegovy or Zepbound for weight loss?
Yes. MO HealthNet covers Zepbound and Foundayo for obesity with prior authorization (BMI 30 or higher, or 27 or higher with a weight-related condition, plus other pathways); Wegovy and Saxenda are not covered for weight loss. This was checked against Missouri's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Missouri expanded Medicaid under the ACA?
Yes - Missouri has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the Missouri state employee health plan cover Wegovy or Zepbound?
We could not verify this. Not verified. None of MCHCP's public plan documents says whether Wegovy, Zepbound, Saxenda or Foundayo are covered for weight loss (the 2026 enrollment guide has no GLP-1 language and the 2026 summary of benefits excludes only 'Weight-loss programs'); the plan's formulary sits behind the member login. Check the current plan documents or ask the plan directly.